Thymoma and the increased risk of developing extrathymic malignancies: A multicentre study

European Journal of Cardio-thoracic Surgery

Volumn 44, Issue 2, 2013, Pages 219-224

  Filosso, Pier Luigi ^a   Galassi, Claudia ^a,b   Ruffini, Enrico ^a   Margaritora, Stefano ^a,c,d   Bertolaccini, Luca ^a,d   Casadio, Caterina ^a,e   Anile, Marco ^a,f   Venuta, Federico ^a,f  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d Centro Oncologico Fiorentino (CFO)   (Italy)

^e S CROCE E CARLE HOSPITAL   (Italy)

^f UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Cancer; Cause of death; Myasthenia gravis; Surgery; Thymoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; AUTOIMMUNE DISEASE; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CANCER SURGERY; CHILD; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; STANDARDIZED INCIDENCE RATIO; THYMOMA;

CANCER; CAUSE OF DEATH; MYASTHENIA GRAVIS; SURGERY; THYMOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEOPLASM METASTASIS; NEOPLASMS, SECOND PRIMARY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THYMOMA;

EID: 84880670578     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs663     Document Type: Article

References (24)

1. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 2004;77: 1860-9.
2. Venuta F, Anile M, Diso D, Vitolo D, Rendina EA, De Giacomo T et al. Thymoma and thymic carcinoma. Eur J Cardiothorac Surg 2010;37: 13-25.
3. Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 2003;105:546-51.
4. Marx A, Hohenberger P, Hoffmann H, Pfannschmidt J, Schnabel P, Hofmann HS, et al. The autoimmune regulator AIRE in thymoma biology. Autoimmune and beyond. J Thorac Oncol 2010;5:S266-72.
5. Strobel P, Helmereich M, Menioudakis G, Lewin SR, Rudiger T, Bauer A, et al. Paraneoplastic myasthenia gravis correlates with generation of mature naïve CD4+ T cells in thymomas. Blood 2002;100:159-66.
6. Okumura M, Fujii Y, Shiono H, Inoue M, Minami M, Utsumi T, et al. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Gen Thorac Cardiovasc Surg 2008;56:143-50.
7. Mueller-Hermelink HK, Marx A. Thymoma. Curr Opin Oncol 2000;12: 426-33.
8. Welsh JS, Wilkins KB, Green R, Bulkey G, Askin F, Diener-West M, et al. Association between thymoma and second neoplasms. JAMA 2000;283: 1142-3.
9. Pan CC, Chen PC, Wang LS, Chi KH, Chiang H. Thymoma is associated with an increased risk of second malignancy. Cancer 2001;92:2406-11.
10. Travis LB, Boice JD, Travis WD. Second primary cancers after thymoma. Int J Cancer 2003;107:868-70.
11. Yen YT, Lai WW, Wu MH, Lin MY, Chang JM, Hsu IL, et al. Thymic neuroendocrine carcinoma and thymoma are both associated with increased risk of extrathymic malignancy: a 20-year review of a single institution. Ann Thorac Surg 2011;91:219-26.
12. Weksler B, Nason KS, Mackkey D, Gallagher A, Pennathur A. Thymomas and extrathymic cancers. Ann Thorac Surg 2012;93:884-9.
13. Gadalla SM, Rajan A, Pfeiffer R, Kristinsson SY, Bjorkolm M, Langden O, et al. A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer 2011;128:2688-94.
14. Levin N, Abramsky O, Lossos A, Karussis D, Siegal T, Argov Z, et al. Extrathymic malignancies in patients with myasthenia gravis. J Neurol Sci 2005;237:39-43.
15. Owe JF, Cvancarova M, Romi F, Gilhus NE. Extrathymic malignancies in thymoma patients with and without myasthenia gravis. J Neurol Sci 2010;290:66-9.
16. Marx A, Strobel P, Zettl A, chan JKC, Harris NL, Kuo TT. Thymomas. In: Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Thymus and Heart. Lyon: IARC Press, 2004, 152-3.
17. Koga K, Matsuno Y, Noguchi M, Mukai K, Asamura H, Goya T, et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994;44:359-67.
18. Ruffini E, Filosso PL, Mossetti C, Bruna MC, Novero D, Lista P, et al. Thymoma: inter-relationships among world Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience. Eur J Cardiothorac Surg 2011;40:146-53.
19. Souadjijan JV, Silverstein MN, Titus JL. Thymoma and cancer. Cancer 1968;22:1221-5.
20. Masaoka A, Yamakawa Y, Niwa H, Fukai I, Tokudome S, Nakahara K, et al. Thymectomy and malignancy. Eur J Cardiothorac Surg 1994;8:251-3.
21. de Jong WK, Blaauwgeers JLG, Schaapveld M, Timens W, Klinkenberg TJ, Groen HJM. Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer 2008;44: 123-30.
22. Boice JD Jr, Land CE, Preston DL. Ionizing radiation. In Shottenfeld D, Fraunemi JF Jr (eds). Cancer Epidemiology and Prevention, 2nd edn. New York: Oxford University Press, 1996, 319-54.
23. Friedmann HD, Inman DA, Hutchison RE, Poiesz BJ. Concurrent invasive thymoma and T-cell lymphoblastic leukemia and lymphoma: a case report with necroscopy findings and literature review of thymoma and associated hematologic neoplasms. Am J Clin Pathol 1994;101: 432-7.
24. Owe JF, Daltveit AK, Gilhus NE. Does myasthenia gravis provide protection against cancer? Acta Neur Scand 2006;113:33-6.